Most cited papers from Grochowski Hospital

Grochowski Hospital

What are the most cited papers from Grochowski Hospital?

The most cited paper from Grochowski Hospital is "Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes" (Lars C. Wallentin, Richard C. Becker, Andrzej Budaj et al., 2009), with 7,154 citations. Next come "Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial" (2,130) and "Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction" (2,003).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 121 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars C. Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine Open access	30 Aug 2009	7,154
2	Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Sanjit S. Jolly, Salim Yusuf, John A. Cairns et al. · The Lancet	Apr 2011	2,130
3	Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Marc P. Bonaca et al. · New England Journal of Medicine Open access	14 Mar 2015	2,003
4	Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Johannes F.E. Mann, Roland Erich Schmieder, Matthew McQueen et al. · The Lancet	Aug 2008	1,593
5	Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Renato D. Lópes et al. · New England Journal of Medicine Open access	17 Mar 2019	1,223
6	Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Shamir R. Mehta et al. · The Lancet	3 Sep 2010	825
7	Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction Klas Malmberg, Salim Yusuf, Hertzel C. Gerstein et al. · Circulation	29 Aug 2000	753
8	Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction Elliott Marshall Antman, David A. Morrow, Carolyn H. McCabe et al. · New England Journal of Medicine Open access	15 Mar 2006	610
9	Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes Philippe Gabríel Steg, Omar H. Dabbous, Laurent J. Feldman et al. · Circulation	26 Jan 2004	552
10	Dronedarone in High-Risk Permanent Atrial Fibrillation Stuart J. Connolly et al. · New England Journal of Medicine Open access	14 Nov 2011	544
11	Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) Kim Allen Eagle, Shaun G. Goodman, Álvaro Avezum et al. · The Lancet	Feb 2002	540
12	Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Jonas Oldgren, Andrzej Budaj, Chris B. Granger et al. · European Heart Journal Open access	7 May 2011	536
13	Acute Coronary Syndromes Without Chest Pain, An Underdiagnosed and Undertreated High-Risk Group David B. Brieger, Kim Allen Eagle, Shaun G. Goodman et al. · CHEST Journal	Aug 2004	523
14	Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus Thomas A. Zelniker, Marc P. Bonaca, Remo H.M. Furtado et al. · Circulation Open access	27 Jan 2020	467
15	Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial Richard C. Becker, Jean‐Pierre Bassand, Andrzej Budaj et al. · European Heart Journal Open access	16 Nov 2011	386
16	Effects of Radial Versus Femoral Artery Access in Patients With Acute Coronary Syndromes With or Without ST-Segment Elevation Shamir R. Mehta, Sanjit S. Jolly, John A. Cairns et al. · Journal of the American College of Cardiology Open access	24 Oct 2012	381
17	Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation Salim Yusuf, Marcus D Flather, Janice Pogue et al. · The Lancet	Aug 1998	360
18	Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) Keith A.A. Fox, Frederick A. Anderson, Omar H. Dabbous et al. · Heart Open access	6 Jun 2006	345
19	Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry) Robert Joel Goldberg, Philippe Gabríel Steg, Immad R Sadiq et al. · The American Journal of Cardiology	Apr 2002	335
20	Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Kausik K Ray et al. · The Lancet Diabetes & Endocrinology Open access1,703 authors	Jul 2019	332
21	Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries Isabelle Johansson et al. · Circulation Open access	28 Apr 2021	308
22	Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes Salim Yusuf, Shamir R. Mehta, Feng Zhao et al. · Circulation Open access	24 Feb 2003	303
23	Implications of Diabetes in Patients With Acute Coronary Syndromes The Global Registry of Acute Coronary Events Kristen Franklin · Archives of Internal Medicine	12 Jul 2004	301
24	Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland Paweł Płudowski et al. · Nutrients Open access	30 Jan 2023	299
25	Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) José J. Santopinto, K A A Fox, R J Goldberg et al. · Heart Open access	15 Aug 2003	297
26	Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial Claes Held, Harvey Douglas White, Ralph Stewart et al. · Journal of the American Heart Association Open access	11 Oct 2017	293
27	Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score Catherine McGorrian, Salim Yusuf, S. Islam et al. · European Heart Journal Open access	22 Dec 2010	288
28	Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients Erin Ann Bohula et al. · New England Journal of Medicine Open access	26 Aug 2018	268
29	Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Shamir R. Mehta, Christopher Bull Granger, John W. Eikelboom et al. · Journal of the American College of Cardiology Open access	Oct 2007	266
30	Hematopoietic stem cell transplantation for multiple sclerosis Αthanasios Fassas et al. · Journal of Neurology	Jul 2002	263
31	Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction Michelle L. O’Donoghue et al. · JAMA Open access	4 Apr 2016	250
32	Premature ovarian failure. Katarzyna K. Jankowska · PubMed	Jun 2017	245
33	Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? Frederick A. Spencer, Mauro M. Moscucci, Christopher Bull Granger et al. · Circulation	19 Nov 2007	233
34	Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups Andrzej Budaj, Salim Yusuf, Shamir R. Mehta et al. · Circulation	23 Sep 2002	229
35	Role of Mitochondrial DNA Damage in ROS-Mediated Pathogenesis of Age-Related Macular Degeneration (AMD) Kai Kaarniranta, Elżbieta Pawłowska, Joanna Szczepańska et al. · International Journal of Molecular Sciences Open access	14 May 2019	204
36	The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes Shaun G. Goodman, Wei Huang, Andrew Tze-Kay Yan et al. · American Heart Journal	18 Jul 2009	203
37	Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy Krzysztof Kiryluk et al. · Nature Genetics Open access188 authors	19 Jun 2023	191
38	Obesity in menopause – our negligence or an unfortunate inevitability? Jarosław Kozakowski, Małgorzata Gietka‐Czernel, Dorota Leszczyńska et al. · Menopause Review/Przegląd Menopauzalny Open access	2017	188
39	Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Andrzej Budaj, John W. Eikelboom, Sweta Mehta et al. · European Heart Journal Open access	18 Aug 2008	186
40	Global Variations in Heart Failure Etiology, Management, and Outcomes G-CHF Investigators et al. · JAMA Open access335 authors	16 May 2023	169
41	Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men Stefan Zgliczyński, Marcin Ossowski, Jadwiga Slowinska-Srzednicka et al. · Atherosclerosis	Mar 1996	168
42	Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y 12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 Marc P. Bonaca et al. · European Heart Journal Open access	21 Oct 2015	167
43	Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 Silke Gillessen et al. · European Journal of Cancer Open access118 authors	2 Mar 2023	166
44	A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Sunil V. Rao et al. · Circulation Open access190 authors	28 Aug 2022	156
45	Pediatrics Consequences of Caesarean Section—A Systematic Review and Meta-Analysis Aneta Słabuszewska-Jóźwiak, Jacek Krzysztof Szymański, Michał Ciebiera et al. · International Journal of Environmental Research and Public Health ReviewOpen access	31 Oct 2020	153
46	Cardioneuroablation for Reflex Syncope Roman Piotrowski, Jakub Marek Baran, Agnieszka Sikorska et al. · JACC. Clinical electrophysiology Open access	28 Aug 2022	150
47	Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome Eliano Pio Navarese, Safi Ullah Khan, Michalina Marta Kołodziejczak et al. · Circulation Open access	29 May 2020	148
48	Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease Daniel P. Lindholm et al. · Journal of the American College of Cardiology Open access	Aug 2017	143
49	Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events) Debabrata Mukherjee, Kim Allen Eagle, Eva M Kline-Rogers et al. · The American Journal of Cardiology	12 May 2007	140
50	Increase in Opiate Prescription in Germany Between 2000 and 2010 Ingrid Schübert, Peter Ihle, Rainer Sabatowski · Deutsches Ärzteblatt international Open access	25 Jan 2013	138

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.